Reforming 340B vital for affordable medication for low-income patients ...Middle East

The Hill - News
Reforming 340B vital for affordable medication for low-income patients
When the 340B drug pricing program was established in 1992, Congress intended for the program to help low-income and uninsured patients with their prescription drugs. The pharmaceutical companies whose drugs are covered by Medicaid are required to participate in the program, offering discounts for drugs to patients on average at 25 to 50 percent of the wholesale acquisition cost.   Unfortunately, today, the 340B program is failing those it was meant to serve. There is ample evidence that special interests have hijacked the program and exploited its loopholes for their own profit.  Take for example the fact that the 340B program has increased in size substantially since the Affordabl

Hence then, the article about reforming 340b vital for affordable medication for low income patients was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Reforming 340B vital for affordable medication for low-income patients )

Apple Storegoogle play

Last updated :

Also on site :